People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| iboss, Inc. | — | Other Technology | Series C | $85.0M | $1.4B | 2020 |
| Anumana, Inc. | — | Biotechnology | Series B | $32.0M | $464.8M | 2022 |
Kyle Bettigole at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kyle Bettigole on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Connolly | 1 | 14 |
| Alan Colowick | 1 | 7 |
| David DeWalt | 1 | 6 |
| Christopher Park | 1 | 4 |
| Harris Fishman | 1 | 4 |
| David Goel | 1 | 3 |
| Albert Hugo Martinez | 1 | 3 |
| George Blank | 1 | 2 |
| Murali Aravamudan | 1 | 2 |
| Justin Sollenne | 1 | 1 |
| Joel Wecksell | 1 | 1 |
| Stephen Hugo Kearns | 1 | 1 |
| Frank Franzilli | 1 | 1 |
| Cheranjit Rihal | 1 | 1 |
| Peter Martini | 1 | 1 |
| Paul Martini | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.